Advertisement
Screener

ENDONOVO THERAPEUTICS, INC. (ENDV) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

1.6 / 5 stars · 18/56 Roast Me

ENDONOVO THERAPEUTICS, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

ENDONOVO THERAPEUTICS, INC. (ENDV) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.15 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2021-04-13.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2021-04-13

  • ENDONOVO THERAPEUTICS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2020 was $0.15, a 98.71% decline from fiscal 2019.
  • ENDONOVO THERAPEUTICS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2019 was $11.60, a 66.14% decline from fiscal 2018.
  • ENDONOVO THERAPEUTICS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2018 was $34.26, a 118037.93% increase from fiscal 2017.
  • ENDONOVO THERAPEUTICS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2017 was $0.03.
Period endShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month as first filed
2020-12-31$0.15
10-K · filed 2021-04-13
2020-09-30$0.15
10-Q · filed 2020-11-19
2019-12-31$11.60
10-K · filed 2021-04-13
2019-09-30$0.01
10-Q · filed 2019-11-19
2019-06-30$0.01
10-Q · filed 2019-08-13
2018-12-31$34.26
10-K · filed 2020-05-04
$0.03
10-K · filed 2019-04-15
2018-09-30$0.03
10-Q · filed 2018-11-13
2017-12-31$0.03
10-K · filed 2019-04-15
2017-09-30$0.03
10-Q/A · filed 2017-11-09
2017-06-30$0.05
10-Q · filed 2017-08-10